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Background: Glutamine appears to mediate protection against gut injury via multiple pathways. These include
fibronectin-integrin, PI3-K/MAPK pathways, and activation of heat shock protein (HSP) response. We hypothesize
there may be a relationship between these pathways mediating glutamine’s protection in intestinal epithelial-6 cells
after heat stress. We assessed whether p38MAPK and PI3-K/Akt signaling are involved in glutamine’s cytoprotective
mechanism and the role they play in glutamine-mediated protection in conjunction with fibronectin-integrin
osmosignaling after hyperthermia.
Methods: Intestinal epithelial cells were treated for 15 min with glutamine, with/without the fibronectin-integrin
interaction inhibitor GRGDSP, inactive control peptide GRGESP, p38MAPK inhibitor SB203580, or PI3-K/Akt inhibitor
LY294002 under basal (37°C) and stressed (43°C or 44°C) conditions. Cell survival was measured via MTS assay 24 h
post-heat stress (44°C × 50 min). Total p38MAPK, [T(P)180/Y(P)182]p38MAPK, total Akt, [S(P)473]Akt, HSP70, FN, and
caspase-3 levels were determined via Western blot after non-lethal HS (43°C × 50 min). Additionally, HSP70 levels
were assessed via Western blot and ELISA.
Results: We were able to show that GRGDSP and LY294002 attenuated glutamine’s protective effect. However,
SB203580 increased cell survival after heat stress. LY294002 attenuated glutamine-mediated increases in fibronectin
and in HSP70 expression after hyperthermia. GRGDSP increased glutamine-mediated attenuations in p38MAPK
phosphorylation, but had no effect on glutamine-mediated augmentations in Akt phosphorylation.
Conclusions: These data suggest that glutamine is protective after heat stress by activating PI3-K/Akt signaling
preventing fibronectin-integrin expression and increasing HSP70 expression. Furthermore, dephosphorylation of
p38MAPK after heat stress plays an important role in glutamine-mediated cellular protection. However, p38MAPK,
but not PI3-K/Akt, signals downstream of glutamine-mediated fibronectin-integrin signaling after hyperthermia.
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GLN is a crucial substrate for the small intestine and
has a central role in numerous metabolic processes in
the gut because of its preferential substrate status in this
organ [1,2]. It serves not only as a precursor of protein,
polyamines, glutathione, and nucleotide synthesis, and
as a nitrogen carrier, but also as the primary metabolic
fuel for enterocytes [2-5]. During illness and malnutri-
tion, GLN-supplemented parenteral and enteral nutri-
tion may become essential for the gut, because GLN
reduces intestinal permeability, decreases bacterial trans-
location, enhances immune function, protects gut mucosa
against injury, accelerates healing of the small intestine,
and improves nitrogen balance in animal models of in-
testinal injury [6-10]. GLN has been studied extensively,
however, its molecular mechanisms of action, especially
the initial key steps, still remain unknown.
In vitro and in vivo studies have shown that GLN can
provide protection by enhancing heat shock protein
(HSP) expression [11,12]. HSPs are highly conserved
proteins involved in the most basic mechanisms of cellu-
lar protection. HSP induction can cause ‘stress tolerance’
and provide protection from subsequent stress that
would otherwise be lethal [13-15]. However, the pathway
by which GLN induces HSP expression appears to be
complex and multifaceted.
GLN is an osmotically acting amino acid, which is
co-transported with sodium into the cell. This causes an
influx of water and induces a ‘cell-swelling’ effect [16].
Osmotic changes are a major physical stress that all cells
undergo. Thus, osmotic-linked cell signaling (osmosig-
naling) plays an essential role in the activation of specific
survival genes [17]. A number of integral membrane
proteins, including integrins have been assigned roles as
upstream sensors of cell volume changes [17-19]. In-
tegrins are a highly conserved family of heterodimeric
adhesion molecules that connect the extracellular ma-
trix (ECM) (e.g. fibronectin (FN)) to intracellular sig-
naling proteins and the cytoskeleton [17,20]. This
unique ability of integrins to regulate attachment of
cells to ECM proteins is called “inside-out signaling”
[21,22]. Ligand binding is transduced from the ECM
to the cytosol by “outside-in signaling” [23]. Thus,
integrins are able to transduce signals in both direc-
tions. FN-Integrin signaling can sense osmotic changes
and was shown to be an essential key step in GLN’s
protective mechanism via Erk1/2, HSF-1, and HSP70
signaling [24].
Further, MAPKs, as well as the phosphoinositol
3-kinase (PI3-K) pathways are crucial downstream
survival signaling cascades from the membrane to the
nucleus [25-27]. Recently, it could be shown that GLN is
protective via ERK1/2 activation and p38MAPK depho-
shorylation in IEC-6 cells after HS [28].In this study we investigated whether p38MAPK and
PI3-K/Akt signaling are involved in GLN’s cytoprotective
mechanism and what role they play in GLN-mediated
protection in conjunction with FN-Integrin osmosigna-
ling after intestinal injury.
Material and methods
All chemicals were purchased from Sigma-Aldrich
(St. Louis, MO), unless otherwise specified.
Cell culture
IEC-6 (ATCC, Manassas, VA) were grown in Dulbecco's
modified Eagle's medium (DMEM), supplemented with
10% fetal bovine serum (FBS), 2 mM L-GLN, 10 ml/l of
antibiotic solution containing penicillin G (10,000U/ml)
and streptomycin (10,000 μg/ml) (Cellgro Mediatech),
and 0.01 mg/ml insulin. Cultured cells were maintained
in a humidified 37°C incubator with 5% CO2. GLN star-
vation was performed by depriving cells of GLN for 24 h
in DMEM, supplemented with 10% FBS and 0.01 mg/ml
insulin.
Heat-stress injury
The model of heat stress injury in IEC-6 cells was used
to mimic intestinal inflammation and injury, because it
represents the most-widely accepted method for in-
ducing a “stress protein response” or heat shock protein
expression [29,30]. For cell viability, 96-well plates were
submerged to a lethal heat stress in a 44°C Precision
water bath Model 260 (Winchester, VI) for 50 min [31]
and allowed to recover at 37°C for 24 h. For protein
expression experiments, cells were subjected to a non-
lethal heat stress at 43°C for 45 min [31] or remained
for 45 min in the 37°C incubator (as control), followed
by a 0 h or a 3 h recovery time.
Protein extraction and Western blot analysis
Cells were seeded in 10 cm dishes and allowed to grow
for 3d in full media. 24 h before the experiment, when
the cells were approximately 80% confluent, the standard
culture full media was replaced by GLN-free, serum
containing DMEM with only 10% FBS and 0.01 mg/mL
insulin for 24 h to standardize GLN content at the start
of each experiment and to mimic the severe GLN deple-
tion occurring in critical illness. Cells were, then, treated
with/without 10 mM GLN for 15 min, with or without
prior 1 h treatment with FN-Integrin inhibitor GRGDSP
(50 μM, diluted in dH20), inactive control peptide
GRGESP (50 μM, diluted in dH20) (Bachem, Torrance,
CA), p38MAPK inhibitor SB203580 (10 μM and 30 μM,
diluted in DMSO), or PI3-K inhibitor LY294002 (25 μM,
diluted in DMSO) and subjected to HS. At the end
of experimental treatment, medium was removed from
the culture, and cells were immediately washed and
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cells were lysed at 4°C using 180 μl M-PER lysis buffer
(Pierce, Rockford, IL) with inhibitor protease and phos-
phatase cocktail (Roche, Indianapolis, IN). Protein was
determined with BCA protein assay (Pierce, Rockford,
IL). 15 μg of each sample were added to a 4× treatment
buffer (250 mM Tris/Cl, 8% SDS, 27.5% glycerol, 20%
2-mercaptoethanol, 0.1% bromphenol blue, pH 6.8),
boiled for 3 min, and then loaded into a NuPAGE
4–12% Bis-Tris Gel (Invitrogen, Carlsbad, CA). Follow-
ing electrophoresis, gels were equilibrated with transfer
buffer (1.2 g Tris/Cl, 7.5 g glycine, 100 ml MeOH,
950 ml dH2O). Proteins were electrophoretically se-
parated with a mini-gel system and transferred to
polyvinylidine difluoride membranes (Millipore, Billerica,
MA), using the biorad wet transfer system. Membranes
were blocked with 5% nonfat milk in PBS-Tween or
5% bovine serum albumin (BSA) in PBS-Tween for
1 h at room temperature. Primary antibodies against
total p38MAPK, [T(P)180/Y(P)182]p38MAPK, total Akt,
[S(P)473]Akt, HSP70, caspase-3 (1:1,000) (Cell signal-
ing, Danvers, MA), and FN were added to antibody
buffer (blocking solution) and incubated overnight at
4°C. After washing three times with PBS-Tween over
30 min, secondary antibodies, peroxidase-conjugated
goat anti-mouse or goat anti-rabbit IgG (Pierce), were
applied at a 1:3,000 dilution for 1,5 h. Blots were washed
three times with PBS-Tween over 30 min, incubated
in commercial enhanced chemiluminescence reagents
(Pierce), and exposed utilizing a UVP chemiluminescent
darkroom system (UVP, Upland, CA). Densitometry was
normalized against β-actin (1:50,000).
HSP70 ELISA
HSP70 levels were also evaluated via HSP70 ELISA
(StressGen, Belgium). IEC-6 cells were treated with the
chemical inhibitor LY294002 (25 μM) as previously de-
scribed, with or without subsequent GLN and heat stress
injury, and allowed to recover for 3 h. Cells were col-
lected, lysed, and assayed for total protein (as specified
in the Western blot analysis section above). 10 μg of
protein was used per well, and the ELISA was performed
via manufacturer’s instructions.
MTS cell viability assay
IEC-6 cells were seeded in 96 well plates (7,000 cells per
well), and allowed to grow for 42 h in full media until
80% confluence. The cells were then cultured for 24 h
in GLN-free, serum containing DMEM. After GLN-
starvation for 24 h, cells were exposed to different con-
centrations of GLN (0 mM, 2 mM, 10 mM) for 15 min.
25 μM LY294002 or 30 μM SB203580 were used 1 h
prior to GLN treatment to inhibit PI3-K and p38MAPK
signaling. Cells were then subjected to lethal HS (asspecified above). Cell viability was evaluated via a soluble
tetrazolioum salt (MTS) assay (Promega, Madison, WI)
as per manufacturer’s instructions 24 h later. Briefly, one
part PMS was added to twenty parts MTS immediately
before the solution was diluted 1:5 in phenol red-free
DMEM and was added to IEC-6 cells. MTS was bio-
reduced by cells into a colored, soluble formazan pro-
duct. Absorbance values were read after 3 h at 490 nm,
using an ELISA plate reader (Thermo Electro Cor-
poration, San Jose, CA); references included readings at
650 nm and no-cell blank wells. Higher absorbance
values reflect greater cell viability. Every well (n = 4 per
group in each experiment) was normalized to their indi-
vidual non-HS controls, to account for possible diffe-
rences in cell growth.
Data analysis and statistics
All experiments were repeated at least 3 times with IEC-
6 cells of different passage numbers [14-22]. Statistical
analysis was validated with GraphPad Prism Analysis
software. Conditions were compared by using one-way
ANOVA, followed by Turkey’s post-hoc test, or student’s
t-test where appropriate, and are expressed as means ±
SEM (number of experiments). Differences were consi-
dered significant at P < .05.
Results
GLN is protective via PI3-K/Akt-HSP70 signaling after HS
The PI3-K/Akt pathway is an intracellular signaling
pathway essential in apoptosis [25]. Our laboratory has
shown, that GLN’s cytoprotective effect is, at least in
part, mediated by increased Hsp70 expression [2]. In this
study, we investigated cell viability in conjunction with
PI3-K inhibitor LY294002 (25 μM) and GLN after ther-
mal injury in IEC-6 cells and were interested whether
Hsp70 expression is regulated via PI3-K/Akt signaling.
MTS assays showed that GLN treatment increased cell
survival in a dose-dependent manner in IEC-6 cells
after lethal HS (P < .001) (Figure 1B). After demonstrat-
ing that 25 μM LY294002 is not toxic to IEC-6 cells
(Figure 1A), we confirmed that PI3-K/Akt signaling was
involved in GLN’s protective mechanism after HS as
LY294002 (25 μM) attenuated GLN’s protection signifi-
cantly (P < .001) (Figure 1B). This result confirms our
previously published data that GLN + LY294002 (25 μM)
treatment increased cleaved Caspase-3 and cleaved
PARP levels in heat-stressed IEC-6 cells [28], sugges-
ting the involvement of PI3-K/Akt signaling in GLN-
protective mechanism in IEC-6 cells after thermal injury.
To determine the effect of LY294002 (25 μM) on GLN-
mediated Hsp70 expression, we examined Hsp70 levels
after HS in IEC-6 via Western blotting and Hsp70
ELISA. Cells treated with 10 mM GLN showed in-
creased Hsp70 levels after HS via Western blot (P < .001)
Figure 1 GLN is protective via PI3-K/Akt-Hsp70 signaling after HS. A) IEC-6 cells were treated with/without 1 h prior LY294002 (25 μM)
treatment under non-stressed conditions (37°C). Cell viability was measured via MTS assay. Results are shown as mean ± SEM (n = 4). B) Cells were
treated for 1 h with or without LY294002 (25 μM) before they were treated with 0, 2, or 10 mM GLN. Cell survival, following lethal HS (44°C), was
measured via MTS assay. All groups were normalized to their non-HS controls to account for differences in cell growth. Assays were carried out in
triplicate, experiments were performed 4 times and are shown as mean ± SEM. C) IEC-6 cells were treated with 0 mM or 10 mM GLN with or
without LY294002 (25 μM) 1 h prior treatment under basal and stressed conditions (43°C). Hsp70 expression was determined by Western blot
analysis (3 h recovery). In addition, ß-actin was measured to normalize total blotted protein. Data are shown as mean fold change relative to
0 mM GLN ± SEM (n = 4). D) Cells were treated as described in Figure 1C. Hsp70 expression is shown via ELISA in ng/ml ± SEM (n = 4).
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IEC-6 cells treated with LY294002 (25 μM), however,
showed a significant decrease in GLN-mediated Hsp70
levels in both, Western blots (P < .001) (Figure 1C) and
Hsp70 ELISA experiments (P < .001) (Figure 1D).
PI3-K/Akt signaling regulates FN expression and does not
signal downstream of GLN-mediated FN-Integrin
osmosignaling after HS
FN-Integrin signaling is essential in GLN-mediated pro-
tection in IEC-6 cells after HS [24]. In this study, we
were able to confirm these results: By using the FN-
Integrin inhibitor GRGDSP (50 μM), we demonstrated
that GLN-mediated decreases in cleaved Caspase-3
levels increased after FN-Integrin interaction inhibitor
GRGDSP treatment (P < .05). Its inactive control peptide
GRGESP (50 μM) had no effect (Figure 2A). Next, we
investigated whether FN-Integrin signaling is essential inGLN-mediated Akt phosphorylation, since it has been
documented that Akt is essential for the “inside-out”
activation of integrins, which in turn mediates matrix as-
sembly (e.g. FN) in fibroblasts [21]. Therefore, we inves-
tigated the role of GLN-mediated PI3-K/Akt signaling in
conjunction with FN-Integrin signaling. HS decreased
total Akt levels, however, when phosphorylated Akt
levels were normalized to their total Akt levels, HS
increased phorphorylated Akt by 2-fold and addition of
10 mM GLN enhanced this effect by 3-fold, as demon-
strated in our previous study [28]. However, adding
GRGDSP (50 μM) and control GRGESP (50 μM) to the
GLN-treated group did not change the 3-fold in-
creases in GLN-mediated Akt phosphorylation (P < .05)
(Figure 2B), suggesting that PI3-K/Akt signals before or in
parallel of FN-Integrin signaling.
FN expression is important to regulate cell survival
and to interact with integrins for osmosignaling [32].
Figure 2 PI3-K/Akt siganling regulates FN-expression and does not signal downstream of GLN-mediated FN-Integrin osmosignaling
after HS. A) IEC-6 cells were treated for 1 h with either media, GRGDSP (50 μM), or GRGESP (50 μM), prior to GLN treatment (0 mM or 10 mM)
under basal (37°C) and stressed conditions (43°C). Procaspase-3, cleaved caspase-3 levels and ß-actin were measured via Western blot and
cleaved Caspase-3 levels are presented as fold change ± SEM (n = 3). B) IEC-6 cells were treated as described in Figure2A. Representative Western
blots of 3 independent experiments of [S(P)473]Akt and total Akt are shown as mean fold change relative to total Akt ± SEM and normalized to
0 mM GLN. C) FN levels with/without GLN (10 mM) and LY294002 (25 μM) treatment under unstressed (37°C) or stressed conditions (43°C)
were determined by Western blot after 3 h recovery. Densitometric analysis of FN expression as mean fold change relative to 0 mM GLN
cells ± SEM (n = 3-8).
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grins, reducing osmosignaling. Our results confirmed
that HS decreased FN (P < .001). However, GLN inhibi-
ted this decrease after HS, as demonstrated by our
laboratory [24]. In this experiment, we added PI3-K/Akt
inhibitor LY294002 (25 μM) to GLN-treated groups and
demonstrated that GLN was not able to prevent FN
expression after HS when LY294002 (25 μM) was added
(P < .001) (Figure 2C).
GLN is protective by dephosphorylating p38MAPK
downstream of GLN-mediatedFN-Integrin osmosignaling
after HS
Since p38MAPK’s pro- or anti-apoptotic functions ap-
pear to be dependent on the cell type and cellular
content [33,34], we examined its role in GLN’s pro-
tective mechanism in IEC-6 cells after hyperthermia.
Therefore, we used the p38MAPK phosphorylation
inhibitor SB203580. We confirmed via Western blot that
SB203580 (10 μM) was able to attenuate p38MAPK
phosphorylation (Figure 3A). After demonstrating in ourrecent publication that SB203580 (10 μM) increased cell
survival after HS in IEC-6 cells, we were interested as
whether higher concentrations of SB203580 would
further increase cell viabilty [28]. Herein, we were able
to show that SB203580 (10 μM and 30 μM) was able to
increase cell survival after lethal HS in a dose-dependent
manner (Figure 3B), suggesting that dephosphorylation
of p38MAPK correlates with cell survival. Next, we
investigated whether FN-Integrin signaling is essential in
GLN-mediated p38MAPK dephosphorylation. Figure 3C
confirmed as previously published [28] that HS in-
creased p38MAPK phosphorylation (P < .05) and 10 mM
GLN attenuated its phosphorylation significantly (P < .05).
GRGDSP (50 μM) altered GLN-mediated p38MAPK
phosphorylation (P < .05), indicating involvement of FN-
Integrin signaling in GLN-mediated p38MAPK signaling
(Figure 3C).
Discussion
Critical illness and inflammatory injuries, such as sepsis,
shock, and inflammatory bowel disease, are one of the
Figure 3 GLN is protective by dephosphorylating p38MAPK
downstream of GLN-mediated FN-Integrin osmosignaling after
HS. A) Cells were treated with 0 mM or 10 mM GLN with or without
SB203580 (10 μM) 1 h prior treatment under stressed conditions
(43°C). A representative Western blot of [T(P)180/Y(P)182]p38MAPK
and total p38MAPK levels is shown. B) IEC-6 cells were treated with/
without 1 h prior SB203580 (10 μM and 30 μM) treatment under
stressed conditions (44°C). Cell survival was measured via MTS assay.
Results are shown as mean ± SEM (n = 4). C) IEC-6 cells were treated
as described in Figure 2A. Western blots of [T(P)180/Y(P)182]p38MAPK
and total p38MAPK levels are shown. P38MAPK phosphorylation is
revealed as mean fold change relative to total p38MAPK ± SEM and
ratioed to 0 mM GLN (n = 4).
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around the world [35,36]. At present, studies to define
new therapeutic interventions that could protect tissues
and cells against injury, attenuate inflammation, and
preserve metabolic function are fields of intense inves-
tigation. GLN seems to be a potential therapeutic in
intestinal diseases, however currently, the molecular
mechanisms and the initiation steps involved in GLN-
mediated protection are not well understood.
Our study provides new mechanistic insights into
GLN’s initial anti-apoptotic steps in the gut after ther-
mal injury. In this study, we show that FN-Integrin,
p38MAPK, and PI3-K/Akt signaling play essential roles
in GLN-mediated cell survival signaling. GLN activated
PI3-K/Akt signaling independently from FN-Integrin
signaling after HS (Figure 2B), prevented FN expression
(Figure 2C), and increased HSP70 expression (Figure 1C
and D) to prevent apoptosis (Figure 1B). Akt1 is crucial
for the “inside-out” activation of integrins, which in turn
mediates matrix assembly [21] and is involved in the
activation of integrins, which is an essential key step
necessary for adhesion in endothelial cells, regulating
ECM assembly [21,37]. Thus, it seemed reasonable to
hypothesize that PI3-K/Akt signaling could regulate
GLN-mediated FN expression and FN-Integrin signaling
via “inside-out” signaling in intestinal epithelial cells to
prevent cell death after intestinal injury.
In this study, we show for the first time that PI3-K/
Akt signaling regulates GLN-mediated FN expression
after hyperthermia (Figure 2C). FN expression is import-
ant for cell survival [32] and is essential in GLN’s pro-
tective mechanism [24]. Degradation of FN leads to less
interaction with integrins, which reduces osmosignaling.
Here, evidence is presented that PI3-K/Akt signaling re-
gulates GLN-mediated FN expression after HS, possibly
via “inside-out” signaling to activate FN-Integrin in-
teractions. Our laboratory recently published that FN-
Integrin interaction inhibitor GRGDSP and the ERK1/2
kinase inhibitor PD98059 attenuated GLN-mediated in-
creases in Hsp70 expression [24]. Thus, it was important
to determine if the PI3-K-inhibitor LY294002 was also
Figure 4 Proposed working model. GLN is protective in IEC-6 cells
by activating PI3-K signaling which prevents FN expression and
increases HSP70 expression after thermal injury. Furthermore, GLN
is protective by dephosphorylating p38MAPK via GLN-mediated
FN-Integrin signaling after HS. GLN-mediated PI3-K/Akt signaling,
however, seems to be independent of FN-Integrin signaling.
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results in Figure 1C and D indicated that PI3-K/Akt
signaling regulated GLN-mediated Hsp70 enhancement
after HS. If our hypothesis is correct and PI3-K/Akt
signaling is able to regulate both FN expression and the
activation of FN-Integrin signaling as part of GLN’s
protective effects, this would be in agreement with our
results showing that both GRGDSP and LY294002
decrease GLN-mediated Hsp70 expression. However, it
could also be possible that PI3-K/Akt signals in parallel
to FN-Integrin signaling to prevent apoptosis via in-
creased Hsp70 expression. This key area of research still
needs to be investigated in future studies. Future experi-
ments with LY294002 or PI3-K siRNA in conjunction
with ERK1/2 and p38MAPK activation should yield
important new mechanistic insights.
As ERK1/2 activation was involved in GLN-mediated
FN-Integrin signaling and as Sakiyama et al. previously
reported that GLN regulated cell survival by p38MAPK
pathway that affected autophagy [38], we evaluated if
GLN-mediated p38MAPK dephosphorylation was also
regulated via FN-Integrin signaling. Exposure of intes-
tinal epithelial cells to the FN-Integrin inhibitor GRGDSP
showed that p38MAPK serves as downstream mediator of
GLN-mediated FN-Integrin signaling (Figure 3C). What
role GLN-mediated FN-Integrin-p38MAPK signaling
plays related to autophagy will be an interesting field
of research in future studies.
In conclusion, as was found for ERK1/2, p38MAPK is
regulated via GLN-mediated FN-Integrin signaling in
intestinal epithelial cells after thermal injury. We assume
that the enhancement of HSP by HS may be the
secondary change for protection against the activation of
p38MAPK. However, the specific order of interactions
between PI3-K/Akt, HSP, and p38MAPK are not known
at present.
GLN-mediated PI3-K signaling, however, either hap-
pens before FN-Integrin signaling or simultaneously
after injury in the intestine. We suggest that GLN-
mediated PI3-K/Akt signaling regulates FN expression
and possibly FN-Integrin osmosignaling after injury.
This induces Hsp70 expression, which is known to
prevent apoptosis. Figure 4 shows an overview of our
current working hypothesis for GLN’s cellular anti-
apoptotic effect. “The effect of p38MAPK inhibition
on HSP70 expression will need to be evaluated in fu-
ture studies. We hypothesize that inhibition of p38MAPK
by GLN may have minimal effects on GLN-mediated
increases in HSP70 expression since we were able to show
in our previous publication that SB203580 did not
increase GLN’s beneficial effect on cell viability in MTS
cell survival assays [28]. However, SB203580 increased cell
survival in heat stressed groups in a dose dependent
manner (Figure 3B)”.Continued basic and clinical research considering GLN
as a potential therapeutic agent in gastrointestinal disease
is essential, since GLN has dynamic effects on the gastro-
intestinal tract and remains an extremely promising
nutrient for metabolic support of patients with intestinal
disorders. This work gives new and potentially clini-
cally relevant mechanistic insights into GLN-mediated
molecular cell survival pathways. These results warrant
clinical translation to assess if clinical outcome of clinical
states of gut injury can be improved by GLN treatment
and/or by targeting the molecular pathways found in this
study.
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